BMC Complementary Medicine and Therapies

OCT 15, 2026 · JOURNAL ARTICLE

Four consecutive weeks of dawn-to-dusk intermittent fasting are associated with improved markers of gut barrier integrity and attenuated subclinical intestinal inflammation in adults with overweight and obesity: a prospective cohort study

BMC Complementary Medicine and Therapies

Inflammatory bowel diseases (IBD) are among the most prevalent immune-mediated inflammatory diseases, with an alarmingly growing prevalence worldwide. Intermittent fasting (IF) reg

OCT 2, 2026 · JOURNAL ARTICLE

Cell-free supernatant of Limosilactobacillus reuteri enhances 5-fluorouracil-induced apoptosis in SW-480 colorectal cancer cells: an in vitro study

BMC Complementary Medicine and Therapies

5-fluorouracil (5-Fu) is a main treatment for colorectal cancer (CRC) but shows limited efficacy and serious side effects, creating a need for novel adjunct therapies. Recent evide

SEP 11, 2026 · JOURNAL ARTICLE

Anti-adipogenic effects of gancaonin N, a bioactive compound from Glycyrrhiza uralensis, in MDI-Induced 3T3-L1 adipocytes

BMC Complementary Medicine and Therapies

Abstract Background Obesity represents a significant global health challenge resulting from the intricate interactions between genetic predispositions, environmental influences, an

SEP 8, 2026 · JOURNAL ARTICLE

Therapeutic potential of the genus Zehneria (Cucurbitaceae): a systematic review of ethnomedicinal uses, phytochemistry, and pharmacological activities, with a predominant focus on Zehneria scabra

BMC Complementary Medicine and Therapies

A systematic review of ethnomedicinal uses and preclinical pharmacology in a plant genus, lacking clinical trial data and relying on fragmented in vitro and animal studies, with the authors themselves concluding that clinical studies are required.

SEP 5, 2026 · JOURNAL ARTICLE

Secondary metabolites from Piper crocatum as natural inhibitors of oral pathogens: in vitro and in silico insights into Streptococcus mutans and Candida albicans

BMC Complementary Medicine and Therapies

In vitro and computational study of natural compounds against oral pathogens; no clinical outcomes, no quantified inhibition data, and explicit call for in vivo validation limits this to exploratory mechanistic work.

SEP 4, 2026 · JOURNAL ARTICLE

A scoping review of non-pharmacological symptom management in head and neck cancer patients during the peri-chemoradiotherapy period

BMC Complementary Medicine and Therapies

A scoping review mapping the landscape of non-pharmacological interventions without quality assessment, effect synthesis, or meta-analysis; descriptive and gap-identifying rather than outcome-determining.

AUG 18, 2026 · JOURNAL ARTICLE

Ginger in supportive therapy against side effects of oncological treatment: a systematic review

BMC Complementary Medicine and Therapies

A systematic review of 24 studies in 2409 cancer patients reporting heterogeneous but predominantly positive results for ginger in reducing chemotherapy-induced nausea, vomiting, and other treatment side effects, though with acknowledged methodological limitations.

AUG 18, 2026 · JOURNAL ARTICLE

Magnetic field-regulated biosynthesis of iron oxide nanoparticles from Alborzia kermanshahica: in vitro assessment for hyperthermia and gastric cancer therapy

BMC Complementary Medicine and Therapies

In vitro mechanistic study of a biosynthesized nanoparticle platform in cancer cells; demonstrates proof-of-concept but lacks in vivo validation, clinical endpoints, or comparison to standard-of-care therapy.